Amcenestrant
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Amcenestrant, covering 2023-03-30 to 2025-11-24. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer [Phase 1, Phase 2]